Enliven Therapeutics Inc Share Price

NASDAQ: ELVN

Small Cap

$19.01

+0.58

(+3.15%)

as on September 18, 2025 at 1:29 am IST

$₹

Enliven Therapeutics Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$18.64
Day's Price Range
$19.5
$19.01
1.95%
Downside
2.58%
Upside
52 Week's Low
52 Week's High
$13.3
52-Week Price Range
$30.03
$19.01
30.04%
Downside
57.97%
Upside

Enliven Therapeutics Inc share price movements today

Previous Close: $18.43
Open: $18.64
Volume: 707.7K
Day's Low - High: $18.64 - $19.5
52 Week Low - High: $13.3 - $30.03

Enliven Therapeutics Inc Historical Returns

1 Month Return: -6.68 %
3 Month Return: -14.56 %
1 Year Return: -15.3 %
3 Year Return: 0 %
5 Year Return: 0 %

Enliven Therapeutics Inc Stock Fundamentals & Key Indicators

Check Enliven Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.1B

EPS (TTM)

-1.59

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-113.9M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

165407800.00%

Enliven Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Enliven Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Enliven Therapeutics Inc	BUY	$1.1B	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Enliven Therapeutics Inc Stock including INR - Dollar returns

The Enliven Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Enliven Therapeutics Inc investment value today

Current value as on today

₹91,960

Returns

₹8,040

(-8.04%)

Returns from Enliven Therapeutics Inc Stock

₹12,638 (-12.64%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Enliven Therapeutics Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Enliven Therapeutics Inc. Average target price of $41.25

Enliven Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Enliven Therapeutics Inc.

What analysts predicted

53.92%UPSIDE

Target Price

$41.25

Current Price

$19.01

Analyzed by

10 Analysts

Target

$41.25

Enliven Therapeutics Inc target price $41.25, a slight upside of 53.92% compared to current price of $19.01. According to 10 analysts rating.

Enliven Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Enliven Therapeutics Inc Stock has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:67% versus previous 30 day period

Enliven Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-16	-20	-24	-22	-25	-24	-27	-26	-31	-28
EBITDA	-16	-20	-24	-22	-25	-24	-26	-26	-31	-28
Interest Expense	1	-	-	1	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-14	-16	-20	-19	-22	-19	-23	-23	-28	-25
Income Tax Expense	-1	0	-3	5	0	0	-	0	-	-
Net Income	-14	-16	-20	-19	-22	-19	-23	-23	-28	-25
Net Profit Margin	0.00%	0.00%	0.00%	-4402.27%	0.00%	0.00%	0.00%	-7335.44%	0.00%	0.00%

Enliven Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-
Gross Profit	0	0	0	0	0
Operating Income	-9	-24	-38	-83	-104
EBITDA	-9	-24	-38	-81	-88
Interest Expense	-	0	1	-	-
Depreciation	0	0	0	0	0
Income Before Tax	-18	-24	1	-71	-88
Income Tax Expense	0	0	0	1	0
Net Income	-18	-24	-37	-71	-89
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Enliven Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-16	-20	-19	-22	-19	-23	-23	-28	-25
Operating Cash Flow	-12	-15	-12	-23	-20	-12	-17	-24	-17
Investing Cash Flow	-151	-35	38	-17	-33	14	0	1	-183
Financing Cash Flow	-2	0	0	90	1	1	39	0	218
Change in Cash	-166	-51	26	49	-52	3	23	-22	17

Enliven Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-11	-23	-18	-24	-37	-71	-89
Operating Cash Flow	-8	-21	-8	-19	-32	-61	-73
Investing Cash Flow	-	-24	0	0	0	-148	-35
Financing Cash Flow	6	43	130	-1	-1	234	133
Change in Cash	-2	-2	121	-20	-34	24	23

Insights on Enliven Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 81.0%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ELVN stock has moved down by -4.5%

About Enliven Therapeutics Inc

enliven therapeutics focuses on the discovery and development of next generation small molecule treatments for cancer. we are backed by top-tier life science venture funds. we seek experienced and passionate drug hunters to join our team as we grow our r&d organization in boulder, co.

Organisation	Enliven Therapeutics Inc
Headquarters	6200 Lookout Road, Boulder, CO, United States, 80301
CEO	Mr. Samuel S. Kintz M.B.A.
E-voting on shares	Click here to vote

Key Management of Enliven Therapeutics Inc

Name	Title
Mr. Samuel S. Kintz M.B.A.	Co-Founder, CEO, Secretary & Director
Dr. Joseph P. Lyssikatos Ph.D.	Co-Founder & Chief Scientific Officer
Dr. Helen Louise Collins M.D.	Chief Medical Officer
Mr. Anish Patel Pharm.D.	Co-Founder & COO
Mr. Benjamin Hohl	CFO & Head of Corporate Development
Dr. Galya D. Blachman Esq., Ph.D.	Chief Legal Officer & Head of Business Development

FAQs

What is Enliven Therapeutics Inc share price today?

Enliven Therapeutics Inc share price today is $19.01 as on September 18, 2025 at 1:29 am IST at the close of the market. Enliven Therapeutics Inc share today touched a day high of $19.5 and a low of $18.64.

What is the 52 week high and 52 week low for Enliven Therapeutics Inc share?

Enliven Therapeutics Inc share touched a 52 week high of $30.03 on October 18, 2024 and a 52 week low of $13.3 on April 10, 2025. Enliven Therapeutics Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $19.01,which is 36.70% down from its 52 week high and 42.93% up from its 52 week low.

What is Enliven Therapeutics Inc's market capitalisation today?

Enliven Therapeutics Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Enliven Therapeutics Inc Stock (ELVN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Enliven Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Enliven Therapeutics Inc Shares that will get you 0.0789 shares as per Enliven Therapeutics Inc share price of $19.01 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Enliven Therapeutics Inc Stock (ELVN) from India?

Indian investors can start investing in Enliven Therapeutics Inc (ELVN) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 12:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Enliven Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 12:39 pm IST). Based on Enliven Therapeutics Inc share’s latest price of $19.01 as on September 18, 2025 at 1:29 am IST, you will get 0.5260 shares of Enliven Therapeutics Inc. Learn more about fractional shares .